Traffic jam:   4


Chief Executive Officer of Pfizer

Organization: Pfizer

Date of Birth: 15 March 1958

Age: 65 years old

Zodiac sign: Pisces

Profession: Chief Executive Officer



Mikael Dolsten is a Swedish-American physician scientist , and the President of research & development-Medical (chief scientific officer) of the American Pharmaceutical company Pfizer.

Early life

He was born Mikael Dohlsten. He is Jewish. 

Dolsten attended Kattegattskolan in Halmstad, Sweden (Kattegattgymnasiet), a gymnasium secondary school in Halmstad, graduating in 1975. He grew up in Halmstad Municipality in the south-west of Sweden.

He studied Medicine from January 1979 to 1985 at Lund University in Sweden and obtained a PhD in cancer immunology 1988 at Lund University. Dolsten was appointed Associate professor 1990 and Adjunct Professor in Immunology 1996. He was selected as top candidate for a Professorship at Uppsala in Immunology 1997. Dolsten has published some 150 original articles and reviews in scientific journals on the topic of immunology, oncology, cell biology, drug discovery and authored several patents. He pursued scientific studies in immunology and virology 1981 at the Weizman Institute of Science in Rehovot Israel.



Dolsten worked from 1988-97 for the Swedish company Pharmacia in Lund. The last few years in this period he served as head of research for the Lund research center working into immune and cancer therapeutics. This company would be bought by Pfizer in 1997.


From 1997-2003 he worked for the Swedish pharmaceutical company Astra that became AstraZeneca as head of research & development for the subsidiary Astra Draco and after the Astra-Zeneca merger as head of Cardiovascular/Metabolic & Gastrointestinal research areas in April 1999, at Mölndal.


He was appointed President of R&D at the American Pharma Wyeth 2008. Dolsten joined Pfizer in 2009 during the acquisition of Wyeth as Head of BioTherapeutics. He became Pfizer's Chief Scientific Officer and President of R&D on 26 May 2010, replacing Martin Mackay, who moved to the UK as head of research for AstraZeneca. In his ongoing more than 10 years of tenure as Chief Scientific Officer at Pfizer a number of significant medicines and vaccines have been approved and used in medical practice, including Prevnar 13, Inlyta, Xeljanz, Eliquis, Xalcori, Bosulif, Daurismo, Lorbrena, Besponsa, Ibrance, Trumenba, Xtandi (acquired from Medivation), Vyndaqel, Eucrisa (acquired from Anacor), Braftovi (acquired from ARRAY), Bavencio, Inflectra (acquired from Hospira), Trazimera, Ruxience, and Zirabev. Dolsten has been part of leading the Pfizer Covid vaccine effort in 2020

On 14 May 2014 he appeared, with two other Pfizer executives, in front of the Science and Technology Select Committee to answer questions. The day before, three Pfizer executives had been interviewed in front of the Business, Innovation and Skills Committee.

Dolsten served as scientific advisor to the Obama administration’s task force for improving regulatory and drug development as well as the VP Biden led Cancer moonshot and the NCI Blue Ribbon Panel. He has been founding co-chair with NIH Director Francis Collins for the public private consortium AMP, Accelerating Medicine Partnership.

He is on an advisory board of the Pharmaceutical Research and Manufacturers of America, Board member of Research America and Board member of the public company Karyopharm Therapeutics in Boston.

Dolsten has been elected to the Royal Swedish Academy of Engineering Science.

Personal life

He is married to Catarina R Dolsten. They have a daughter (Josefin) and two sons (Simon and Gabriel). Mikael Dolsten moved to the USA in 2004 with his family. He is a dual Swedish–American citizen.

Rating GlobalNY.biz

Takes place
Takes place
In rating
Takes place

Mentioned together

Assistant Professor at Mount Sinai School of Medicine
1 place


Chief Development Officer, Inflammation & Immunology at Pfizer
1 place
Senior Vice President and Chief Development Officer, Internal Medicine and Hospital, Pfizer
2 place
Chief Development Officer, Oncology and Rare Disease, Pfizer
3 place
Global President, Vaccines, Pfizer Biopharmaceuticals Group
4 place
Chairman and Chief Executive Officer of Pfizer
5 place
Founder of Pfizer
6 place

Born in one day

Date of Birth: 15.03.1958. Age: 65. Zodiac sign: Pisces (Dog) .
Horoscope Pisces: horoscope for today, horoscope for tomorrow, horoscope for week, horoscope for month, horoscope for year.
Days left until next birthday: 12 Days.
American college basketball player
1 place
American football coach
2 place
Real estate investor and landlord based in New York City, and founder of the Witkoff Group
3 place
4 place
Co-founder of Robinhood
5 place
Associate Justice of the Supreme Court of the United States
6 place
Co-founder of MPower
7 place
7th president of the United States
8 place
Co-founder of The Honest Company
9 place


Profile statistic

Companies rating
National Football League (NFL)
40 Persons
National Basketball Association (NBA)
24 Persons
Major League Baseball (MLB)
24 Persons
Morgan Stanley
20 Persons
Ultimate Fighting Championship (UFC)
20 Persons
19 Persons
United States House of Representatives
17 Persons
White House
16 Persons
15 Persons
Foot Locker
14 Persons
GlobalNY.biz pays special attention to the activities of famous people: politicians, officials, businessmen, bankers, cultural and sports figures. Their opinion largely determines the development of political, social and economic life in New York. The section is constantly edited by our journalists for the relevance of information. Here you can find information about CEOs and presidents of top New York companies, officials and public figures who play a key role in the development of the region.
The goal of the project is to create a comfortable information space for all market actors, as well as to acquaint the readership with business people in New York.
We have created an impressive database of people in New York, which contains information about a career path, education and other important information about a person.
Thanks to automatic counting of the number of mentions of a person in the news sections " New York News ”and“ New York Press Releases ”on the portal the rating of popularity and influence of persons is formed. The GlobalNY.biz team monitors rating changes and rewards project participants for their success. In general, the rating of participants is based on an in-depth analysis of the activity of PR services of famous people, and also reflects the qualitative state of the information field formed by the media and press services around the organization.
Business People of New York is a project about people who, through their ideas, words and deeds, have a great influence on the development and prosperity of New York.
Alena Potapova

Development Director
Died this year
Born this year